A double-blind placebo-controlled study of the efficacy and safety of non-prescription ranitidine 75 mg in the prevention of meal-induced heartburn

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 4, 1999, Pages 467-473

  Pappa, K A ^a   Williams, B O ^a   Payne, J E ^a   Buaron, K S ^a   Mussari, K L ^a   Ciociola, A A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DRUGS, NON-PRESCRIPTION; FEMALE; FOOD; HEARTBURN; HUMANS; MALE; RANITIDINE; TREATMENT OUTCOME;

EID: 0032942713     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00505.x     Document Type: Article

References (32)

1. A Gallup Survey on Heartburn Across America Princeton, NJ: Gallup Organization, 1988.
2. Nebel TO, Fornes MF, Castell DO. Symptomatic gastro-esophageal reflux: Incidence and precipitating factors. Dig Dis Sci 1976; 21: 953-6.
3. Graham DY, Smith JL, Patterson DJ. Why do apparently healthy people use antacid tablets? Am J Gastroenterol 1983; 78: 257-60.
4. Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of oesophageal disorders. Scand J Gastroenterol 1991; 26: 73-81.
5. Greenwood B, Rodriguez SL, Miner PN, et al. A comparison of three provocative meals: Effects on intraesophageal pH and heartburn symptoms. Gastroenterology 1996; 110: A123 (Abstract).
6. Gottlieb S, Decktor DL, Eckert JM, et al. Efficacy and tolerability of famotidine in preventing heartburn and related symptoms of upper gastrointestinal discomfort. Am J Ther 1995; 2: 314-19.
7. Kitchin LI, Castell DO. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med 1991; 151: 448-454.
8. Yeoh KG, Ho KY, Guan R. How does chili cause upper gastrointestinal symptoms? J Clin Gastroenterol 1995; 2: 87-90.
9. Myers BM, Smith JL, Graham DY. Effect of red pepper and black pepper on the stomach. Am J Gastroenterol 1987; 82: 211-14.
10. Sanchez-Palomera E. Concept of the mucosa barrier and its significance. II. Changes in gastric mucosa produced by the local actions of spices and other irritative agents. Gastroenterology 1951; 18: 269-86.
11. Richter JE. Heartburn, dysphagia, odynophagia, and other esophageal symptoms. Gastrointestinal Disease. Filth Edn. Philadelphia: WB Saunders Co., 1993: 331-40.
12. Scanner Audit Data. Chicago, IL: Information Resources Inc., 1997.
13. Nebel TO, Castell D. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 1972; 63: 778-83.
14. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastro-esophageal reflux in subjects with reflux oesophagitis. N Engl J Med 1982; 307: 1547-52.
15. ZANTAC® 150 Tablets, USP. Prescription Product Information. Research Triangle Park, NC: Glaxo Wellcome Inc., December 1997.
16. Wyeth JW, Pounder RE, Sercombe JC, Snell CCL. The effects of low doses of ranitidine on intragastric acidity in healthy men. Aliment Pharmacol Ther 1998; 12: 255-61.
17. Sirgo MA, Pappa KA, Giefer EE, et al. Low dose ranitidine for the treatment of episodic heartburn. Am J Gastroenterol 1995; 90: 1572 (Abstract).
18. Sirgo MA, Webster CJ, Geifer EE, et al. Worldwide clinical trial adverse event safety profile of ranitidine. Gastroenterology 1995; 108: A36 (Abstract).
19. Pappa KA, Buaron KS, Mandich M, et al. A double-masked, placebo-controlled study of the efficacy and safety of premeal ranitidine in the prevention or reduction of heartburn. Curr Ther Res 1998; 59: 454-66.
20. Sontag S, Robinson M, McCallum RW, et al. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Arch Intern Med 1987; 147: 1485-91.
21. Gonzalez JC, da Silva N, Diaz D, et al. Cimetidine versus ranitidine in the treatment of reflux oesophagitis. Dig Dis Sci 1986; 31: A1858 (Abstract).
22. Berlin R, Ebel D, Cook T, Famotidine 40 at bedtime versus ranitidine 150 bid in the treatment of reflux oesophagitis: The results of a multicenter trial. Gastroenterology 1989: 96: A39 (Abstract).
23. Voi M, Birkett M, Brandstaetter G, et al. A comparison of the sefety and efficacy of two doses of nizatidine versus ranitidine in patients with erosive gastro-oesophageal reflux disease. Hellen Gastroenterol 1992; 5(Suppl.): 1495.
24. Spiegel JE, Thoden WR, Pappas K, et al. A double-blind, placebo-controlled study of the effectiveness and safety of nizatidine in the prevention of postprandial heartburn. Arch Intern Med 1997; 157: 1594-9.
25. Tagamet® HB, Prevention of Meal-Induced Heartburn, Acid Indigestion, and Sour Stomach when Taken 30 Minutes Prior to Consuming Food or Beverages. Summary Basis of Approval. Rockville, MD: US Food and Drug Adminstration, 1995.
26. Pappa KA, Kelly R, Payne E et al. Ranitidine 75 mg for prevention of meal-induced heartburn. Gastroenterology 1997; 112: A251 (Abstract).
27. 2-antagonists: Great expectations unfulfilled. Gastroenterology 1998; 114: A41 (Abstract).
28. Friedman C, Lanza F, Ryan J, et al. The natural history and reproducibility of meal-induced heartburn. Gastroenterology 1987; 92: A1397 (Abstract).
29. Lanza FL, Smith V, Page-Castell JA, et al. Effectiveness of a foaming antacid in relieving induced heartburn. South Med J 1986; 79: 327-30.
30. Feldman M. Comparison of the effects of over-the-counter famotidine and calcium carbonate on postprandial gastric acid. J Am Med Assoc 1996; 275: 1428-31.
31. Mann SG, Cottrell J, Murakami A, et al. Prevention of heartburn relapse by low dose famotidine: A test meal model for duration of symptom control. Aliment Pharmacol Ther 1997; 11: 121-7.
32. Silvers D, Jokubaitis L, Napolitano J. Cisapride 20 mg twice daily prevents heartburn and reduces the severity of other meal-related symptoms following ingestion of a fatty meal. Am J Gastroenterol 1997; 92: A1625 (Abstract).